跳至主要内容
临床试验/NCT04178863
NCT04178863Unknown4 期

Efficacy of Topical Latanoprost 0.005% Verses Timolol 0.5% Demonstrated by Corneal Biomechanical Correcting Modified Goldmann Prism

Intuor Technologies, Inc.1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2018年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
72
试验地点
1
主要终点
IOP reduction

研究概览

简要总结

Topical Prostaglandin Analog vs Betablocker - Corneal Biomechanical Evaluation using CATS Tonometer Prism

详细描述

This clinical trial is a prospective, controlled, study and will be performed at one clinical investigative site in Tucson Arizona1. The purpose of this study is to determine if the device, CATS tonometer prism, measures intraocular pressure significantly differently than the current standard of care tonometer prism (Goldmann) before and after institution of topical prostaglandin analogs (PGA) for glaucoma treatment. Fifty percent of patients will be randomly placed on topical beta blockers as a control. The difference PGAs and beta blockers would be a measurement of the amount of corneal biomechanical changes made due to the PGA controlled for the effect of IOP lowering by the beta -blocker group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 101 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Male and female patients, at least 18 years of age
  • Subject has a clear understanding and agrees to all the conditions of the informed consent form

排除标准

  • Subjects shall be selected in accordance with the following exclusion criteria
  • Subject has undergone ocular surgery within the last 3 months
  • Uncontrolled systemic disease that in the opinion of the Investigator would put the subject's heath at risk
  • Pregnant or nursing women
  • Those who have had corneal surgery including corneal laser surgery
  • Microphthalmos
  • Buphthalmos
  • Severe Dry eyes
  • Lid squeezers - blepharospasm
  • Nystagmus
  • corneal or conjunctival infection.

研究组 & 干预措施

lataprost

Active Comparator

latanoprost use

干预措施: CATS Tonometer (Device)

timolol

Active Comparator

timolol group

干预措施: CATS Tonometer (Device)

timolol

Active Comparator

timolol group

干预措施: Latanoprost (Drug)

结局指标

主要结局

IOP reduction

时间窗: 1 month

次要结局

未报告次要终点

研究者

发起方
Intuor Technologies, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验